ECI PHARMS LLC FDA Approval ANDA 209945

ANDA 209945

ECI PHARMS LLC

FDA Drug Application

Application #209945

Application Sponsors

ANDA 209945ECI PHARMS LLC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL250MG0TRIENTINE HYDROCHLORIDETRIENTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-08-13STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

ECI PHARMS LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209945
            [companyName] => ECI PHARMS LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIENTINE HYDROCHLORIDE","activeIngredients":"TRIENTINE HYDROCHLORIDE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/13\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-08-13
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.